Beware: Common diabetic drug can trigger rare COVID-19 complications

Diabetes patients on glucose-lowering drugs are at risk of rare COVID-19 complications, especially those drugs that induce release of excess glucose via urine. Read on to know more.

By: Jahnavi Sarma | | Updated: December 30, 2020 9:19 am

In diabetes patients, rare but severe complications, like the potentially lethal condition diabetic ketoacidosis (DKA), can arise when illness or certain conditions prevent cells from receiving enough glucose to fuel their functioning.

It is a known fact that people with diabetes are at a greater risk of COVID-19 complications as are people with other underlying health conditions like hypertension and heart disease. Over the course of the last year, when the pandemic payed out across the globe, experts have seen many common medications used to treat some chronic ailments may have an adverse effect on infected patients. At the same time, some of these drugs have also had a favourable effect on COVID-19 patients. Scientists have been conducting studies to see the adverse effects of widely used drugs on COVID positive patients. Also Read - Beware! Coronavirus can damage your brain in many ways. Here’s what to know

Now, researchers say that diabetes patients on glucose-lowering drugs are at risk of rare COVID-19 complications, especially those who use a popular class of diabetes drugs called sodium-glucose cotransporter 2 inhibitors (SGLT2i), which function by releasing excess glucose in the urine. In diabetes patients, rare but severe complications, like the potentially lethal condition diabetic ketoacidosis (DKA), can arise when illness or certain conditions prevent cells from receiving enough glucose to fuel their functioning. Also Read - Genome sequencing of sewage water can help discover new coronavirus variants: US scientists

It can lead to complications by causing buildup of ketones

The researchers at Brigham and Women’s Hospital observed an uptick in a particular type of DKA called euDKA during the pandemic. EuDKA is a subset of the diabetes complication known as DKA, which occurs when the body’s cells fail to absorb enough glucose and compensate by metabolizing fats instead, creating a build-up of acids called ketones. EuDKA differs from DKA in that it is characterised by lower blood sugar levels, making it more difficult to diagnose. Underlying nearly all euDKA cases is a state of starvation that can be triggered by illnesses that cause vomiting, diarrhea, and loss of appetite and can be compounded by the diuretic effect of SGLT2i drugs, noted the study published in The American Association of Clinical Endocrinologists Clinical Case Reports. Also Read - 'Game changer against Covid-19': Expert panel recommends phase 1 trial of Bharat Biotech's nasal vaccine

Dangers of SGLT2 inhibitors

Researchers say that they have the background knowledge of recognising that SGLT2 inhibitors can cause DKA and euDKA. Their report reinforces that if patients are ill or have loss of appetite or are fasting, they should pause their medication and not resume until they are well and eating properly. Brigham researchers studied five unusual euDKA cases brought to the diabetes inpatient services within the span of two months, three of which occurred in one week, at the height of the pandemic in Boston in the spring of 2020. The authors also suspect that COVID-19 may particularly exacerbate euDKA risks.

Virus may destroy insulin producing cells

When the virus infects a patient, it binds to cells on the pancreas that produce insulin and may exert a toxic effect on them. Studies of the earlier SARS-CoV-1 virus found that many infected patients had increased blood sugar. It’s been posited through other models that the virus may be preferentially destroying insulin-producing cells. The authors encourage patients and physicians to halt SGLT2i-use in the event of illness, which is already standard practice for the most common diabetes drug, metformin.

(With inputs from IANS)

Published : December 29, 2020 4:23 pm | Updated:December 30, 2020 9:19 am

Read Disclaimer